Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 2

Wave 3 of this Tracking Report is now available here!

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have changed over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.


  • Method: 10-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illnesses
  • Sample Size: n=159 Total Patients (Previous Wave: 152), 83 Mild to Moderate Patients (Previous Wave: 77), 76 Moderate to Severe Patients (Previous Wave: 75)
  • Fielding Period: May 7th – 8th, 2020 (Previous Wave: March 25th – 26th)

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more